デフォルト表紙
市場調査レポート
商品コード
1712653

ウェアラブル注射器の世界市場レポート 2025年

Wearable Injectors Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
ウェアラブル注射器の世界市場レポート 2025年
出版日: 2025年04月09日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ウェアラブル注射器の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR15.2%で174億5,000万米ドルに成長します。予測期間の成長は、個別化医療、遠隔患者モニタリング、医薬品開発、慢性疾患管理に起因しています。予測期間の主な動向には、生物製剤と大型分子、デュアルチャンバー型ウェアラブル、コネクテッドデバイスとスマートデバイス、パッチポンプ技術が含まれます。

糖尿病、心血管疾患、がんなどの慢性疾患の有病率の上昇は、ウェアラブル注射器市場の成長に大きく寄与しています。例えば、2023年4月、糖尿病患者を支援する英国の慈善団体British Diabetic Associationの報告書によると、英国では約430万人が糖尿病と診断されています。このうち約90%が2型糖尿病、約8%が1型糖尿病、残り2%がその他の糖尿病と診断されています。糖尿病やその他の慢性疾患患者の増加により、治療ソリューションに対する需要が高まり、ウェアラブル注射器市場の拡大を牽引しています。

高齢者人口の増加は、今後のウェアラブル注射器市場拡大の原動力になると予想されます。この層は、通常65歳以上の高齢者で構成されており、ウェアラブル注射器は、彼らに薬を自己管理する便利な方法を提供し、頻繁な通院の必要性を減らすと同時に、自立性と治療計画の遵守を促進します。例えば、2022年10月、世界保健機関(WHO)は、2030年までに世界全体で6人に1人が60歳以上になると報告し、2050年までに21億人の高齢者が存在すると予測しています。したがって、老人人口の増加はウェアラブル注射器市場拡大の主要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界ウェアラブル注射器PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のウェアラブル注射器市場:成長率分析
  • 世界のウェアラブル注射器市場の実績:規模と成長, 2019-2024
  • 世界のウェアラブル注射器市場の予測:規模と成長, 2024-2029, 2034F
  • 世界ウェアラブル注射器総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のウェアラブル注射器市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 体内注射器
  • オフボディインジェクター
  • 世界のウェアラブル注射器市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • クリニック
  • 在宅ケア環境
  • 世界のウェアラブル注射器市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 免疫腫瘍学
  • 糖尿病
  • 心血管疾患
  • その他の用途
  • 世界のウェアラブル注射器市場、オンボディインジェクターの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • パッチベースのインジェクター
  • 接着剤ベースのインジェクター
  • 針式注射器
  • 無針注射器
  • 世界のウェアラブル注射器市場オフボディインジェクターの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ベルトベースインジェクター
  • ハンドヘルドインジェクター
  • クリップ式インジェクター

第7章 地域別・国別分析

  • 世界のウェアラブル注射器市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のウェアラブル注射器市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ウェアラブル注射器市場:競合情勢
  • ウェアラブル注射器市場:企業プロファイル
    • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company(BD)Overview, Products and Services, Strategy and Financial Analysis
    • Enable Injections LLC Overview, Products and Services, Strategy and Financial Analysis
    • Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Medtronic MiniMed Inc.
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Sensile Medical AG
  • Gerresheimer AG
  • Dexcom Inc.
  • Consort Medical plc
  • United Therapeutics Corporation
  • Buhler Motor GmbH
  • Debiotech SA
  • Cellnovo Group
  • EoFlow Co. Ltd.
  • CeQur SA
  • Haselmeier AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ウェアラブル注射器市場2029:新たな機会を提供する国
  • ウェアラブル注射器市場2029:新たな機会を提供するセグメント
  • ウェアラブル注射器市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r32863

Wearable injectors are specialized drug delivery devices that affix to the patient's body during the subcutaneous administration of drugs over a predetermined duration.

These wearable injectors come in two primary types are on-body injectors and off-body injectors. On-body injectors are drug delivery devices attached directly to the patient's skin, typically on the abdomen or the back of the patient's arm. They find applications in various medical fields, including immuno-oncology, diabetes, cardiovascular diseases, among others, and are employed across a range of healthcare settings, including hospitals, clinics, and home care.

The wearable injectors market research report is one of a series of new reports from The Business Research Company that provides wearable injectors market statistics, including wearable injectors industry global market size, regional shares, competitors with a wearable injectors market share, detailed wearable injectors market segments, market trends and opportunities, and any further data you may need to thrive in the wearable injectors industry. This wearable injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wearable injectors market size has grown rapidly in recent years. It will grow from $8.84 billion in 2024 to $9.91 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.

The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $17.45 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.

The rise in the prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancers has significantly contributed to the growth of the wearable injectors market. For example, in April 2023, a report from the British Diabetic Association, a UK-based charity supporting individuals with diabetes, highlighted that approximately 4.3 million people in the UK are diagnosed with diabetes. Of these, around 90% have type 2 diabetes, about 8% are diagnosed with type 1 diabetes, and the remaining 2% have other forms of diabetes. The increasing number of patients with diabetes and other chronic conditions has led to a greater demand for treatment solutions, driving the expansion of the wearable injectors market.

The increasing elderly population is expected to be a driving force behind the growth of the wearable injectors market in the future. This demographic consists of older adults, typically aged 65 and above, and wearable injectors offer them a convenient way to self-administer medications, fostering independence and adherence to treatment regimens while reducing the necessity for frequent hospital visits. For example, in October 2022, the World Health Organization reported that globally, one in six individuals would be 60 years old or older by 2030, and it is projected that there will be 2.1 billion elderly individuals by 2050. Hence, the growing geriatric population is a key driver of the wearable injectors market's expansion.

Many companies in the wearable injectors manufacturing market are focusing on developing advanced products such as on-body injectors (OBI) to enhance patient convenience, improve adherence to prescribed treatments, and meet the rising demand for self-administration of biologics. An On-Body Injector (OBI) is a wearable drug delivery device designed to administer medications subcutaneously over a specific period, providing convenience for patients who require large-volume or timed-dose injections. For example, in February 2024, Coherus BioSciences Inc., a US-based biotechnology company, launched UDENYCA, an advanced drug delivery device using the LTS Sorrel wearable platform. This device is designed to administer pegfilgrastim-cbqv, a biosimilar of pegfilgrastim, used the day after chemotherapy to reduce the risk of febrile neutropenia, a condition marked by fever and low white blood cell count due to infections. The OBI ensures precise dosing and convenience by enabling at-home administration, removing the need for additional clinic visits.

Major players in the wearable injectors market are increasingly focusing on introducing innovative medication delivery devices like the enFuse injector to enhance their revenue in the market. The enFuse injector is designed for the self-administration of high-volume drugs, offering patients comfort and convenience. For instance, in September 2023, Enable Injections, Inc., a US-based medical technology company, obtained approval from the US Food and Drug Administration (FDA) for the enFuse injector. This wearable injector is intended for the subcutaneous delivery of EMPAVELI, a medication used by adults with paroxysmal nocturnal hemoglobinuria (PNH) and marketed in the United States by Apellis Pharmaceuticals Inc. The enFuse injector is a compact, wearable device that simplifies the self-administration process with minimal disruption to patients' daily routines. It enables hands-free delivery of up to 25 mL, making it suitable for use at home or in clinical settings. The FDA approval of the enFuse injector provides patients with a more convenient way to administer their medication.

In June 2023, LTS LOHMANN Therapie-Systeme AG, a pharmaceutical company based in Germany, purchased the Sorrel wearable injection device business from Eitan Medical for an undisclosed sum. This acquisition is anticipated to broaden LTS LOHMANN Therapie-Systeme AG's range of drug delivery platforms and enhance its offerings in the areas of large molecules and biologics. Eitan Medical Ltd. is an Israeli medical device company known for its development of innovative drug delivery solutions, including wearable injectors.

Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical PLC, United Therapeutics Corporation, Buhler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd., Zosano Pharma Corporation

North America was the largest region in the wearable injectors market in 2024. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wearable injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The wearable injectors market consists of sales of instruments such as on-body injectors and off-body injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wearable Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wearable injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wearable injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wearable injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: On-Body Injectors; Off-Body Injectors
  • 2) By End-User: Hospitals; Clinics; Homecare setting
  • 3) By Application: Immuno-Oncology; Diabetes; Cardiovascular Diseases; Other Applications
  • Subsegments:
  • 1) By On-Body Injectors: Patch-Based Injectors; Adhesive-Based Injectors; Needle-Based Injectors; Needle-Free Injectors
  • 2) By Off-Body Injectors: Belt-Based Injectors; Handheld Injectors; Clip-Based Injectors
  • Companies Mentioned: Amgen Inc.; Becton Dickinson and Company (BD); Enable Injections LLC; Insulet Corporation; Ypsomed Holding AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wearable Injectors Market Characteristics

3. Wearable Injectors Market Trends And Strategies

4. Wearable Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Wearable Injectors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wearable Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wearable Injectors Market Growth Rate Analysis
  • 5.4. Global Wearable Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wearable Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wearable Injectors Total Addressable Market (TAM)

6. Wearable Injectors Market Segmentation

  • 6.1. Global Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Body Injectors
  • Off-Body Injectors
  • 6.2. Global Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare setting
  • 6.3. Global Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immuno-Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Other Applications
  • 6.4. Global Wearable Injectors Market, Sub-Segmentation Of On-Body Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patch-Based Injectors
  • Adhesive-Based Injectors
  • Needle-Based Injectors
  • Needle-Free Injectors
  • 6.5. Global Wearable Injectors Market, Sub-Segmentation Of Off-Body Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Belt-Based Injectors
  • Handheld Injectors
  • Clip-Based Injectors

7. Wearable Injectors Market Regional And Country Analysis

  • 7.1. Global Wearable Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wearable Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wearable Injectors Market

  • 8.1. Asia-Pacific Wearable Injectors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wearable Injectors Market

  • 9.1. China Wearable Injectors Market Overview
  • 9.2. China Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wearable Injectors Market

  • 10.1. India Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wearable Injectors Market

  • 11.1. Japan Wearable Injectors Market Overview
  • 11.2. Japan Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wearable Injectors Market

  • 12.1. Australia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wearable Injectors Market

  • 13.1. Indonesia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wearable Injectors Market

  • 14.1. South Korea Wearable Injectors Market Overview
  • 14.2. South Korea Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wearable Injectors Market

  • 15.1. Western Europe Wearable Injectors Market Overview
  • 15.2. Western Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wearable Injectors Market

  • 16.1. UK Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wearable Injectors Market

  • 17.1. Germany Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wearable Injectors Market

  • 18.1. France Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wearable Injectors Market

  • 19.1. Italy Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wearable Injectors Market

  • 20.1. Spain Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wearable Injectors Market

  • 21.1. Eastern Europe Wearable Injectors Market Overview
  • 21.2. Eastern Europe Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wearable Injectors Market

  • 22.1. Russia Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wearable Injectors Market

  • 23.1. North America Wearable Injectors Market Overview
  • 23.2. North America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wearable Injectors Market

  • 24.1. USA Wearable Injectors Market Overview
  • 24.2. USA Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wearable Injectors Market

  • 25.1. Canada Wearable Injectors Market Overview
  • 25.2. Canada Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wearable Injectors Market

  • 26.1. South America Wearable Injectors Market Overview
  • 26.2. South America Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wearable Injectors Market

  • 27.1. Brazil Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wearable Injectors Market

  • 28.1. Middle East Wearable Injectors Market Overview
  • 28.2. Middle East Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wearable Injectors Market

  • 29.1. Africa Wearable Injectors Market Overview
  • 29.2. Africa Wearable Injectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wearable Injectors Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wearable Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wearable Injectors Market Competitive Landscape And Company Profiles

  • 30.1. Wearable Injectors Market Competitive Landscape
  • 30.2. Wearable Injectors Market Company Profiles
    • 30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Enable Injections LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Ypsomed Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Wearable Injectors Market Other Major And Innovative Companies

  • 31.1. Medtronic MiniMed Inc.
  • 31.2. Tandem Diabetes Care Inc.
  • 31.3. Valeritas Inc.
  • 31.4. West Pharmaceutical Services Inc.
  • 31.5. Sensile Medical AG
  • 31.6. Gerresheimer AG
  • 31.7. Dexcom Inc.
  • 31.8. Consort Medical plc
  • 31.9. United Therapeutics Corporation
  • 31.10. Buhler Motor GmbH
  • 31.11. Debiotech SA
  • 31.12. Cellnovo Group
  • 31.13. EoFlow Co. Ltd.
  • 31.14. CeQur SA
  • 31.15. Haselmeier AG

32. Global Wearable Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wearable Injectors Market

34. Recent Developments In The Wearable Injectors Market

35. Wearable Injectors Market High Potential Countries, Segments and Strategies

  • 35.1 Wearable Injectors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wearable Injectors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wearable Injectors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer